plerixafor has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardellini, A; Lanza, F; Laszlo, D; Martino, M | 1 |
| Semple, G | 1 |
| Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Mohty, M; Selleslag, D; Wiktor-Jedrzejczak, W; Worel, N | 1 |
3 other study(ies) available for plerixafor and Obesity
| Article | Year |
|---|---|
Plerixafor: what we still have to learn.
Topics: Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Obesity; Overweight; Patient Selection; Transplantation, Autologous | 2015 |
Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual Conference.
Topics: Animals; Anti-HIV Agents; Benzazepines; Benzylamines; Calcium Channel Blockers; Chemistry, Pharmaceutical; Coronary Artery Disease; Cyclams; Drug Discovery; Heterocyclic Compounds; Humans; Ileus; Lactones; Macrocyclic Compounds; Obesity; Pyridines; Receptor, PAR-1; Receptors, CXCR4; Receptors, Ghrelin; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2010 |
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
Topics: Adult; Aged; Aged, 80 and over; Benzylamines; Body Mass Index; Contraindications; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Obesity; Overweight; Retrospective Studies; Thinness; Young Adult | 2012 |